Literature DB >> 1738804

A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy.

S E Robertson1, L E Markowitz, D A Berry, E F Dini, W A Orenstein.   

Abstract

Between February 8 and April 4, 1986, an outbreak of measles occurred in the State of Arkansas. A total of 489 suspected measles cases were reported from 53 counties; 86 schools statewide reported suspected measles cases. There were 284 cases confirmed in 18 counties; 23.6 percent among students in one university and 41.2 percent among students in kindergarten through 12th grade in 32 schools. An epidemiologic investigation was carried out to evaluate risk factors for vaccine failure and to assess the effectiveness of a selective revaccination strategy in the outbreak setting. A cohort study conducted at a junior high school showed that, compared with students vaccinated against measles at ages 15 months or older, those vaccinated at ages 12-14 months had a three-fold increased risk of measles (relative risk 3.2, 95 percent confidence interval 1.5, 6.9). For schools reporting measles, the Arkansas Department of Health and the Department of Education jointly required reimmunization of students vaccinated at ages younger than 15 months and the exclusion of students not vaccinated at ages 15 months or older until they were vaccinated or until 2 weeks after the last rash onset. To implement these recommendations, more than 100,000 doses of combined measles-mumps-rubella vaccine were distributed at a cost greater than $1 million.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1738804      PMCID: PMC1403597     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  5 in total

Review 1.  Duration of live measles vaccine-induced immunity.

Authors:  L E Markowitz; S R Preblud; P E Fine; W A Orenstein
Journal:  Pediatr Infect Dis J       Date:  1990-02       Impact factor: 2.129

Review 2.  Assessing vaccine efficacy in the field. Further observations.

Authors:  W A Orenstein; R H Bernier; A R Hinman
Journal:  Epidemiol Rev       Date:  1988       Impact factor: 6.222

3.  Patterns of transmission in measles outbreaks in the United States, 1985-1986.

Authors:  L E Markowitz; S R Preblud; W A Orenstein; E Z Rovira; N C Adams; C E Hawkins; A R Hinman
Journal:  N Engl J Med       Date:  1989-01-12       Impact factor: 91.245

4.  Field evaluation of vaccine efficacy.

Authors:  W A Orenstein; R H Bernier; T J Dondero; A R Hinman; J S Marks; K J Bart; B Sirotkin
Journal:  Bull World Health Organ       Date:  1985       Impact factor: 9.408

Review 5.  Appropriate age for measles vaccination in the United States.

Authors:  W A Orenstein; L Markowitz; S R Preblud; A R Hinman; A Tomasi; K J Bart
Journal:  Dev Biol Stand       Date:  1986
  5 in total
  9 in total

1.  Twice vaccinated recipients are better protected against epidemic measles than are single dose recipients of measles containing vaccine.

Authors:  M Paunio; H Peltola; M Valle; I Davidkin; M Virtanen; O P Heinonen
Journal:  J Epidemiol Community Health       Date:  1999-03       Impact factor: 3.710

Review 2.  Prevention of infectious disease transmission in sports.

Authors:  E E Mast; R A Goodman
Journal:  Sports Med       Date:  1997-07       Impact factor: 11.136

3.  Surveillance of measles in England and Wales: implications of a national saliva testing programme.

Authors:  M Ramsay; R Brugha; D Brown
Journal:  Bull World Health Organ       Date:  1997       Impact factor: 9.408

4.  Outbreak of measles among persons with secondary vaccine failure, China, 2018.

Authors:  Zhujiazi Zhang; Meng Chen; Rui Ma; Jingbin Pan; Luodan Suo; Li Lu
Journal:  Hum Vaccin Immunother       Date:  2019-09-05       Impact factor: 3.452

5.  Surveillance for the Expanded Programme on Immunization.

Authors:  F T Cutts; R J Waldman; H M Zoffman
Journal:  Bull World Health Organ       Date:  1993       Impact factor: 9.408

6.  Salivary diagnosis of measles: a study of notified cases in the United Kingdom, 1991-3.

Authors:  D W Brown; M E Ramsay; A F Richards; E Miller
Journal:  BMJ       Date:  1994-04-16

Review 7.  Measles control in the United States: problems of the past and challenges for the future.

Authors:  D L Wood; P A Brunell
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

8.  Predicting the herd immunity threshold during an outbreak: a recursive approach.

Authors:  Nathan T Georgette
Journal:  PLoS One       Date:  2009-01-09       Impact factor: 3.240

9.  Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis.

Authors:  Sara Carazo; Marie-Noëlle Billard; Amélie Boutin; Gaston De Serres
Journal:  BMC Infect Dis       Date:  2020-03-29       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.